Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition used for treating liver cancer

A technology for the treatment of liver cancer and its composition, applied in the field of biomedicine, can solve the problems of high toxicity, poor curative effect, and high cost of treatment

Inactive Publication Date: 2015-04-01
JINAN XINGYI MEDICAL TECH
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

More than 90% of them are in the middle or late stage when they are diagnosed, and most of the opportunities for surgery have been missed. Therefore, the use of modern comprehensive treatment methods is often limited due to radiotherapy, chemotherapy and immunotherapy; and radiotherapy and chemotherapy have great side effects on the treatment of this disease. , the indications are reduced, and the curative effect is also poor; although interventional therapy has a certain curative effect, it requires quite high conditions and equipment, and the cost is relatively large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition used for treating liver cancer
  • Pharmaceutical composition used for treating liver cancer
  • Pharmaceutical composition used for treating liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: the pharmaceutical composition for the treatment of liver cancer

[0024] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of liver cancer are:

[0025] 11 parts by weight of oleuropein, 28 parts by weight of curcumol, 10 parts by weight of gentianin A, and 40 parts by weight of acantholin A.

Embodiment 2

[0026] Embodiment 2: the pharmaceutical composition for the treatment of liver cancer

[0027] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of liver cancer are:

[0028] 33 parts by weight of oleuropein, 16 parts by weight of curcumol, 25 parts by weight of gentianin A, and 30 parts by weight of acanthin A.

Embodiment 3

[0029] Embodiment 3: the pharmaceutical composition for the treatment of liver cancer

[0030] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of liver cancer are:

[0031] 22 parts by weight of oleuropein, 20 parts by weight of curcumol, 17 parts by weight of gentianin A, and 35 parts by weight of acantholin A.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition used for treating liver cancer. The pharmaceutical composition is prepared by taking oleuropein, curcumenol, hemslecin, and justicidin A as drug substances via mixing. Different dosage forms can be obtained via conventional pharmaceutical technology. The pharmaceutical composition possesses significant importance on preparation of medicines used for treating liver cancer.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a pharmaceutical composition for treating liver cancer. Background technique [0002] According to statistics from the Ministry of Health in February 2010, the number of cancer deaths worldwide reaches 10 million each year. At present, one-quarter of the global population's death is caused by cancer, and it is predicted that if the current trend continues, one-half of the deaths will be due to cancer by 2050. The incidence of malignant cancer in my country is increasing at a rate of 2.5-5% per year, and it has become the culprit that seriously endangers human life. Among various types of cancer, the incidence rate of liver cancer is relatively high. [0003] Liver cancer refers to malignant tumors that occur in the liver, including primary liver cancer and metastatic liver cancer. People usually refer to primary liver cancer when they say liver cancer. Primary liver cancer is one of th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61P35/00A61K31/575A61K31/36A61K31/352
Inventor 孔倩倩
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com